ProSci research programs include cancer bio marker discovery and neutralizing antibody development against emergent viruses such as HIV and influenza. ProSci’s innovative approach research using genetically engineered yeast strain and glycoproteins to mimic the HIV-1 glycan coat and develop neutralizing antibodies against HIV-1 glycans has been awarded several Small Business Innovative Research (SBIR) grants by NIH. Its research projects have resulted in an invention patent granted by the U.S. Patent and Trademark Office, and a number of peer-reviewed publications.